Browse By: Country ι Category ι Publisher ι Tag
Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014
Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Cerebral Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cerebral Stroke. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Cerebral Stroke. This report is built using data and information sourced from propriet
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Ischemic Stroke Global Clinical Trials Review, H2, 2014
Ischemic Stroke Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ischemic Stroke Global Clinical Trials Review, H2, 2014" provides data on the Ischemic Stroke clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Stroke. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Stroke. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014
Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Lower Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Lower Limb Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lower Limb Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lower Limb Muscle Spasticity. This report is built using data and information s
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014
Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lumbar Spinal Stenosis. This report is built using data and information sourced from proprietary databa
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014
Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2014" provides data on the Metachromatic Leukodystrophy (MLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metachromatic Leukodystrophy (MLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metachromatic Leukodystrophy (MLD). This report is buil
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Mania Global Clinical Trials Review, H2, 2014
Mania Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of ind
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Multiple Sclerosis Global Clinical Trials Review, H2, 2014
Multiple Sclerosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Multiple Sclerosis Global Clinical Trials Review, H2, 2014" provides data on the Multiple Sclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Sclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Multiple Sclerosis. This report is built using data and information sourced from proprietary databases, primary and sec
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Muscle Spasticity Global Clinical Trials Review, H2, 2014
Muscle Spasticity Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Myalgia Global Clinical Trials Review, H2, 2014
Myalgia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Myalgia Global Clinical Trials Review, H2, 2014" provides data on the Myalgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myalgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myalgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's t
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Myoclonus Global Clinical Trials Review, H2, 2014
Myoclonus Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Neuralgia Global Clinical Trials Review, H2, 2014
Neuralgia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Neuralgia Global Clinical Trials Review, H2, 2014" provides data on the Neuralgia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuralgia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuralgia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
The Pharmaceutical Market: South Africa
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA The government drive to support local production and reduce the country\'s reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market. Headline Expenditure Projections Pharmaceuti
Published Date: Jul 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: United Arab Emirates
OVERVIEW OF THE PHARMACEUTICAL MARKET IN UNITED ARAB EMIRATES The United Arab Emirates\'healthcare and pharmaceutical markets continue to be thestrongest in the region.Its growth prospects arestrong -we forecast high single-digit CAGRsover the course of our 10-year forecast period. Several factors are driving growth: incomes are high, as isthe UAE\'s expatriate population.These elements combine to increase private healthcare expenditure and demand for innovative drugs. Local drug production facilities are also gaining strength, with domestic player Julphar opening a new factory, and multinational drug firms are also entering the market. In addition, there areplans forseveral new hospital and healthcare facilities,whichwill boost future demand for pharmaceuticals. The UAE\'s appeal
Published Date: Jul 2014
Published By: Espicom

Price: $1295
The Pharmaceutical Market: Qatar
Qatar Pharmaceuticals & Healthcare Report According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets, syrups and injectables. It is anticipated the drug manufacturers will (in our view eventually) help curb reliance on imports and lower prices of retail medicines in the country as a result of increased local competition, according to Dr Aisha al-Ansari of the Supreme Council of Health Pharmacy and Drug Control Department (SCH). If the production facilities are opened on schedule, we will revise our forecasts accordingly. Generally speaking, however, we expect Qatar to remain greatly reliant on imported medicines, given the high level of consumption of p
Published Date: Jul 2014
Published By: Espicom

Price: $1295
Follicular Lymphoma - Pipeline Review, H2 2014
Global Markets Directs, Follicular Lymphoma Pipeline Review, H2 2014, provides an overview of the Follicular Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Follicular Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Lymphoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H2 2014
Global Markets Directs, Vancomycin-Resistant Enterococcus Faecium Infections Pipeline Review, H2 2014, provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections and special features on late-stage and discontinued projects. Global Markets Directs re
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014, provides an overview of the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Epithelial Ovarian Cancer - Pipeline Review, H2 2014
Epithelial Ovarian Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Epithelial Ovarian Cancer - Pipeline Review, H2 2014, provides an overview of the Epithelial Ovarian Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epithelial Ovarian Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Chronic Heart Failure - Pipeline Review, H2 2014
Chronic Heart Failure - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chronic Heart Failure - Pipeline Review, H2 2014, provides an overview of the Chronic Heart Failures therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2014, provides an overview of the Spinal Muscular Atrophy (SMA)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Muscular Atrophy (SMA) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Open-Angle Glaucoma - Pipeline Review, H2 2014
Open-Angle Glaucoma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Open-Angle Glaucoma - Pipeline Review, H2 2014, provides an overview of the Open-Angle Glaucomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Open-Angle Glaucoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2014
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2014, provides an overview of the Gastrointestinal Stromal Tumor (GIST)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastrointestinal Stromal Tumor (GIST) and special features on late-stage and discontinued projects.Global Markets Directs r
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Brain Tumor - Pipeline Review, H2 2014
Brain Tumor - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Brain Tumor - Pipeline Review, H2 2014, provides an overview of the Brain Tumors therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Brain Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Tumor and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Malignant Mesothelioma - Pipeline Review, H2 2014
Malignant Mesothelioma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Malignant Mesothelioma - Pipeline Review, H2 2014, provides an overview of the Malignant Mesotheliomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Myocardial Infarction - Pipeline Review, H2 2014
Myocardial Infarction - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Myocardial Infarction - Pipeline Review, H2 2014, provides an overview of the Myocardial Infarctions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Myocardial Infarction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocardial Infarction and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Neurofibromatoses Type II - Pipeline Review, H2 2014
Neurofibromatoses Type II - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Neurofibromatoses Type II - Pipeline Review, H2 2014, provides an overview of the Neurofibromatoses Type IIs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Neurofibromatoses Type II, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neurofibromatoses Type II and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Anaplastic Astrocytoma - Pipeline Review, H2 2014
Anaplastic Astrocytoma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Anaplastic Astrocytoma - Pipeline Review, H2 2014, provides an overview of the Anaplastic Astrocytomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Astrocytoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anaplastic Astrocytoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Respiratory Depression - Pipeline Review, H2 2014
Respiratory Depression - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Respiratory Depression - Pipeline Review, H2 2014, provides an overview of the Respiratory Depressions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Respiratory Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Respiratory Depression and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Equine Encephalitis - Pipeline Review, H2 2014
Equine Encephalitis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Equine Encephalitis - Pipeline Review, H2 2014, provides an overview of the Equine Encephalitiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Equine Encephalitis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Bone Marrow Transplantation - Pipeline Review, H2 2014
Bone Marrow Transplantation - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Bone Marrow Transplantation - Pipeline Review, H2 2014, provides an overview of the Bone Marrow Transplantations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bone Marrow Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Marrow Transplantation and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across g
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2014
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2014, provides an overview of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press r
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Familial Hypercholesterolemia (
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Batten Disease - Pipeline Review, H2 2014
Batten Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Batten Disease - Pipeline Review, H2 2014, provides an overview of the Batten Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Batten Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Batten Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Cirrhosis - Pipeline Review, H2 2014
Cirrhosis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Cirrhosis - Pipeline Review, H2 2014, provides an overview of the Cirrhosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cirrhosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usin
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Diabetic Gastroparesis - Pipeline Review, H2 2014
Diabetic Gastroparesis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Diabetic Gastroparesis - Pipeline Review, H2 2014, provides an overview of the Diabetic Gastroparesiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Diabetic Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Gastroparesis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2014, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type Cs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acid Sphingomyelinase D
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Cholera - Pipeline Review, H2 2014
Cholera - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Cholera - Pipeline Review, H2 2014, provides an overview of the Choleras therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cholera, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cholera and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2014
AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2014, provides an overview of the AIDS - Related Kaposi's Sarcomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $2000
Merrimack Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Merrimack Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Merrimack Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Merrimack Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Merrimack Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Arbovax, Inc. - Product Pipeline Review - 2014
Arbovax, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Arbovax, Inc. - Product Pipeline Review - 2014, provides an overview of the Arbovax, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Arbovax, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
CytoTools AG - Product Pipeline Review - 2014
CytoTools AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, CytoTools AG - Product Pipeline Review - 2014, provides an overview of the CytoTools AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of CytoTools AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Delenex Therapeutics AG - Product Pipeline Review - 2014
Delenex Therapeutics AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Delenex Therapeutics AG - Product Pipeline Review - 2014, provides an overview of the Delenex Therapeutics AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Delenex Therapeutics AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Mucosis B.V. - Product Pipeline Review - 2014
Mucosis B.V. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Mucosis B.V. - Product Pipeline Review - 2014, provides an overview of the Mucosis B.V.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Mucosis B.V.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Acceleron Pharma, Inc. - Product Pipeline Review - 2014
Acceleron Pharma, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Acceleron Pharma, Inc. - Product Pipeline Review - 2014, provides an overview of the Acceleron Pharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acceleron Pharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Venus Remedies Limited - Product Pipeline Review - 2014
Venus Remedies Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Venus Remedies Limited - Product Pipeline Review - 2014, provides an overview of the Venus Remedies Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Venus Remedies Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014
Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Dong Wha Pharma Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Dong Wha Pharma Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Dong Wha Pharma Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2014
Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2014, provides an overview of the Dr. Reddy's Laboratories Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Dr. Reddy's Laboratories Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coverin
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Immupharma Plc - Product Pipeline Review - 2014
Immupharma Plc - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Immupharma Plc - Product Pipeline Review - 2014, provides an overview of the Immupharma Plcs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Immupharma Plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is buil
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Bone Medical Limited - Product Pipeline Review - 2014
Bone Medical Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Bone Medical Limited - Product Pipeline Review - 2014, provides an overview of the Bone Medical Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Bone Medical Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
AC Immune SA - Product Pipeline Review - 2014
AC Immune SA - Product Pipeline Review - 2014SummaryGlobal Markets Directs, AC Immune SA - Product Pipeline Review - 2014, provides an overview of the AC Immune SAs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of AC Immune SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
PhytoHealth Corporation - Product Pipeline Review - 2014
PhytoHealth Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, PhytoHealth Corporation - Product Pipeline Review - 2014, provides an overview of the PhytoHealth Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of PhytoHealth Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Neurotec Pharma SL - Product Pipeline Review - 2014
Neurotec Pharma SL - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Neurotec Pharma SL - Product Pipeline Review - 2014, provides an overview of the Neurotec Pharma SLs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Neurotec Pharma SLs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Th
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Virobay Inc. - Product Pipeline Review - 2014
Virobay Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Virobay Inc. - Product Pipeline Review - 2014, provides an overview of the Virobay Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Virobay Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Prana Biotechnology Limited - Product Pipeline Review - 2014
Prana Biotechnology Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Prana Biotechnology Limited - Product Pipeline Review - 2014, provides an overview of the Prana Biotechnology Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Prana Biotechnology Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Oscotec Inc. - Product Pipeline Review - 2014
Oscotec Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Oscotec Inc. - Product Pipeline Review - 2014, provides an overview of the Oscotec Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Oscotec Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Genexine, Inc. - Product Pipeline Review - 2014
Genexine, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Genexine, Inc. - Product Pipeline Review - 2014, provides an overview of the Genexine, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Genexine, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is buil
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Ensemble Discovery Corporation - Product Pipeline Review - 2014
Ensemble Discovery Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Ensemble Discovery Corporation - Product Pipeline Review - 2014, provides an overview of the Ensemble Discovery Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Ensemble Discovery Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Aestus Therapeutics, Inc. - Product Pipeline Review - 2014
Aestus Therapeutics, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Aestus Therapeutics, Inc. - Product Pipeline Review - 2014, provides an overview of the Aestus Therapeutics, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Aestus Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Euroscreen S.A. - Product Pipeline Review - 2014
Euroscreen S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Euroscreen S.A. - Product Pipeline Review - 2014, provides an overview of the Euroscreen S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Euroscreen S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
OncoTherapy Science, Inc. - Product Pipeline Review - 2014
OncoTherapy Science, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, OncoTherapy Science, Inc. - Product Pipeline Review - 2014, provides an overview of the OncoTherapy Science, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of OncoTherapy Science, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2014
Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2014, provides an overview of the Foresee Pharmaceuticals, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Foresee Pharmaceuticals, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Nobelpharma Co., Ltd. - Product Pipeline Review - 2014
Nobelpharma Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Nobelpharma Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Nobelpharma Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Nobelpharma Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 ind
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Aegera Therapeutics Inc. - Product Pipeline Review - 2014
Aegera Therapeutics Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Aegera Therapeutics Inc. - Product Pipeline Review - 2014, provides an overview of the Aegera Therapeutics Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Aegera Therapeutics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and near
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014
Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Amorfix Life Sciences Ltd. - Product Pipeline Review - 2014, provides an overview of the Amorfix Life Sciences Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Amorfix Life Sciences Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014
CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, CureFAKtor Pharmaceuticals. LLC - Product Pipeline Review - 2014, provides an overview of the CureFAKtor Pharmaceuticals. LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of CureFAKtor Pharmaceuticals. LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Dicerna Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Dicerna Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Dicerna Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
SuppreMol GmbH - Product Pipeline Review - 2014
SuppreMol GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, SuppreMol GmbH - Product Pipeline Review - 2014, provides an overview of the SuppreMol GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of SuppreMol GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is buil
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Bio3 Research S.r.l - Product Pipeline Review - 2014
Bio3 Research S.r.l - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Bio3 Research S.r.l - Product Pipeline Review - 2014, provides an overview of the Bio3 Research S.r.ls pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Bio3 Research S.r.ls, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Neuralstem, Inc. - Product Pipeline Review - 2014
Neuralstem, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Neuralstem, Inc. - Product Pipeline Review - 2014, provides an overview of the Neuralstem, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Neuralstem, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Mebiopharm Co., Ltd. - Product Pipeline Review - 2014
Mebiopharm Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Mebiopharm Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Mebiopharm Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Mebiopharm Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicat
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Mologen AG - Product Pipeline Review - 2014
Mologen AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Mologen AG - Product Pipeline Review - 2014, provides an overview of the Mologen AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Mologen AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Phylogica Limited - Product Pipeline Review - 2014
Phylogica Limited - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Phylogica Limited - Product Pipeline Review - 2014, provides an overview of the Phylogica Limiteds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Phylogica Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Phynova Group Ltd - Product Pipeline Review - 2014
Phynova Group Ltd - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Phynova Group Ltd - Product Pipeline Review - 2014, provides an overview of the Phynova Group Ltds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Phynova Group Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
MolMed S.p.A. - Product Pipeline Review - 2014
MolMed S.p.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, MolMed S.p.A. - Product Pipeline Review - 2014, provides an overview of the MolMed S.p.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of MolMed S.p.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014
Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Yungjin Pharm Ind. Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Yungjin Pharm Ind. Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Yungjin Pharm Ind. Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Zyngenia, Inc. - Product Pipeline Review - 2014
Zyngenia, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Zyngenia, Inc. - Product Pipeline Review - 2014, provides an overview of the Zyngenia, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Zyngenia, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is buil
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges from asymptomatic cases, to classic dengue fever, and to dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) that have a mortality rate of 5%-15%.  Because there are no marketed dengue-specific vaccines or therapeutics, current treatment strategies are limited to supportive ca
Published Date: Jul 2014
Published By: GlobalData

Price: $5995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape United Arab Emirates. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the UAE, identifying key trends in its healthcare market and providing insights into its demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts. In 2013, the UAEs population stood at 9 million, an incre
Published Date: Jul 2014
Published By: GlobalData

Price: $1995
Generalized Seizures Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Generalized Seizures Global Clinical Trials Review, H2, 2014\" provides data on the Generalized Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Generalized Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014\" provides data on the Generalized Tonic-Clonic Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Tonic-Clonic Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Generalized Tonic-Clonic Seizure. This report is built using data and information sourced from proprietary databases, primary and second
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014\" provides data on the Hypoxic-Ischemic Encephalopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxic-Ischemic Encephalopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.  The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypoxic-Ischemic Encephalopathy. This report is built using data and information sourced from proprietary databases, primary and s
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Insomnia Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Insomnia Global Clinical Trials Review, H2, 2014\" provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insomnia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insomnia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of industry experts. Scope Da
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014\" provides data on the Intracerebral Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracerebral Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracerebral Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Intracranial Hypertension Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Intracranial Hypertension Global Clinical Trials Review, H2, 2014\" provides data on the Intracranial Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intracranial Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intracranial Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house an
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Myoclonic Seizures Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Myoclonic Seizures Global Clinical Trials Review, H2, 2014\" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Neonatal Seizures Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Neonatal Seizures Global Clinical Trials Review, H2, 2014\" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neonatal Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Partial Seizure Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Partial Seizure Global Clinical Trials Review, H2, 2014\" provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Partial Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Partial Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of industry
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014
GlobalData\'s clinical trial report, Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014\" provides data on the Polymyalgia Rheumatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polymyalgia Rheumatica. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polymyalgia Rheumatica. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Gl
Published Date: Jul 2014
Published By: GlobalData

Price: $2500
Micronutrients Market (Boron, Copper, Iron, Manganese, Molybdenum, Zinc and Others) for Fertigation, Foliar, Soil, Seed Treatment and Other Applications for Cereals, Pulses & Oilseeds, Fruits & Vegetables and Other Crop Types in Non-chelated and Chelated Forms - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
The report provides forecast and analysis of the micronutrients market on a global and regional level. The study provides historical data of 2013 along with forecast from 2014 to 2020 based on volumes (Kilo Tons) and revenue (USD Million). The report includes drivers and restraints for the micronutrients market along with their impact on demand during the forecast period. Additionally, the report comprises an analysis of opportunities available in the micronutrients market on the global and regional level. The drivers, restraints and opportunities mentioned in the report are justified with the help of quantitative and qualitative data which is verified by primary and secondary resources. We have included a detailed value chain analysis in order to provide a comprehensive view of the
Published Date: Jul 2014
Published By: Transparency Market Research

Price: $4795
Amura Holdings Ltd. - Product Pipeline Review - 2014
Amura Holdings Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Amura Holdings Ltd. - Product Pipeline Review - 2014, provides an overview of the Amura Holdings Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Amura Holdings Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
VG Life Sciences, Inc. - Product Pipeline Review - 2014
VG Life Sciences, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, VG Life Sciences, Inc. - Product Pipeline Review - 2014, provides an overview of the VG Life Sciences, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of VG Life Sciences, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
R-Tech Ueno, Ltd. - Product Pipeline Review - 2014
R-Tech Ueno, Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, R-Tech Ueno, Ltd. - Product Pipeline Review - 2014, provides an overview of the R-Tech Ueno, Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of R-Tech Ueno, Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The re
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Prothelia, Inc. - Product Pipeline Review - 2014
Prothelia, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Prothelia, Inc. - Product Pipeline Review - 2014, provides an overview of the Prothelia, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Prothelia, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Sanwa Kagaku Kenkyusho Co., Ltd. - Product Pipeline Review - 2014
Sanwa Kagaku Kenkyusho Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Sanwa Kagaku Kenkyusho Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the Sanwa Kagaku Kenkyusho Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Sanwa Kagaku Kenkyusho Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe coverin
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Nuformix Ltd - Product Pipeline Review - 2014
Nuformix Ltd - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Nuformix Ltd - Product Pipeline Review - 2014, provides an overview of the Nuformix Ltds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Nuformix Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Futura Medical plc - Product Pipeline Review - 2014
al plc - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Futura Medical plc - Product Pipeline Review - 2014, provides an overview of the Futura Medical plcs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Futura Medical plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
HRA Pharma - Product Pipeline Review - 2014
HRA Pharma - Product Pipeline Review - 2014SummaryGlobal Markets Directs, HRA Pharma - Product Pipeline Review - 2014, provides an overview of the HRA Pharma, SAs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of HRA Pharma, SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Recardio GmbH - Product Pipeline Review - 2014
Recardio GmbH - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Recardio GmbH - Product Pipeline Review - 2014, provides an overview of the Recardio GmbHs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Recardio GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Pharma Two B Ltd - Product Pipeline Review - 2014
Pharma Two B Ltd - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pharma Two B Ltd - Product Pipeline Review - 2014, provides an overview of the Pharma Two B Ltds pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pharma Two B Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500
Vaxon Biotech - Product Pipeline Review - 2014
Vaxon Biotech - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Vaxon Biotech - Product Pipeline Review - 2014, provides an overview of the Vaxon Biotechs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxon Biotechs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Jul 2014
Published By: Global Markets Direct

Price: $1500